Company

Millipede, Inc.

Millipede develops transcatheter annuloplasty ring systems for mitral regurgitation and valve repair.

About

Founded in 2012, Millipede develops IRIS transcatheter annuloplasty ring systems for mitral regurgitation and valve repair. The company is based in Santa Rosa, US. In January 2018, it raised USD 90 million in venture funding from Boston Scientific.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in